Kiniksa Pharmaceuticals International, PLC (KNSA) SEC Filings — 2025
15 SEC filings for Kiniksa Pharmaceuticals International, PLC (KNSA) in 2025.
Filings
- Kiniksa Swings to Profit on 61% ARCALYST Revenue Jump — 10-Q · Oct 28, 2025
- Kiniksa Pharmaceuticals 8-K Filing — 8-K · Sep 3, 2025
- Kiniksa Pharmaceuticals Files 8-K on Operations — 8-K · Jul 29, 2025
- Kiniksa's Q2 Net Loss Widens to $43.4M Amid Rising Expenses — 10-Q · Jul 29, 2025
- Kiniksa Pharmaceuticals Files 8-K — 8-K · Jun 5, 2025
- Kiniksa Pharmaceuticals 8-K Filing on Shareholder Votes — 8-K · Jun 3, 2025
- Kiniksa Pharma Files 2025 Proxy Statement — DEFA14A · May 28, 2025
- Kiniksa Pharma Files Proxy Materials — DEFA14A · May 9, 2025
- Kiniksa Pharmaceuticals Files 8-K on Financials — 8-K · Apr 29, 2025
- Kiniksa Pharmaceuticals Q1 2025 Update — 10-Q · Apr 29, 2025
- Kiniksa Pharma Reports Director/Officer Changes & Compensatory Info — 8-K · Apr 23, 2025
- Kiniksa Pharma Files 2025 Proxy Statement — DEF 14A · Apr 21, 2025
- Kiniksa Pharmaceuticals Terminates Material Agreement — 8-K · Feb 25, 2025
- Kiniksa Pharmaceuticals: $35.8M Assets vs $41.9M Liabilities in 2024 — 10-K · Feb 25, 2025
- Kiniksa Pharmaceuticals Files 8-K on Financials — 8-K · Jan 13, 2025